Perceptive Advisors - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$40,376,000
+39.9%
1,143,7900.0%0.51%
+64.8%
Q4 2020$28,869,000
-33.1%
1,143,7900.0%0.31%
-50.8%
Q3 2020$43,132,000
-34.8%
1,143,790
-25.9%
0.63%
-41.2%
Q2 2020$66,105,000
+120.3%
1,543,7900.0%1.07%
+37.0%
Q1 2020$30,011,000
-25.2%
1,543,7900.0%0.78%
-1.9%
Q4 2019$40,107,000
-4.7%
1,543,7900.0%0.80%
-29.7%
Q3 2019$42,075,000
+1.5%
1,543,7900.0%1.13%
+19.2%
Q2 2019$41,450,000
-7.1%
1,543,7900.0%0.95%
-24.5%
Q1 2019$44,630,000
+7.4%
1,543,7900.0%1.26%
-20.4%
Q4 2018$41,574,0001,543,7901.58%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
VV Manager LLC 4,087,521$111,426,00082.89%
Wildcat Capital Management, LLC 906,194$24,698,00010.49%
TPG Group Holdings (SBS) Advisors, Inc. 42,432,612$1,156,500,0008.54%
Coastal Bridge Advisors, LLC 824,617$22,475,0007.68%
BAINCO INTERNATIONAL INVESTORS 355,913$9,700,0001.50%
Avoro Capital Advisors LLC 1,128,594$30,760,0001.28%
Perceptive Advisors 1,543,790$42,075,0001.13%
Capital Impact Advisors, LLC 75,418$2,055,0000.78%
DSAM Partners (London) Ltd 107,441$2,928,0000.55%
SHIKIAR ASSET MANAGEMENT INC 34,995$954,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders